Disclosure to genetic relatives without consent - Australian genetic professionals' awareness of the health privacy law

被引:13
作者
Meggiolaro, Natalia [1 ]
Barlow-Stewart, Kristine [1 ]
Dunlop, Kate [2 ]
Newson, Ainsley J. [3 ]
Fleming, Jane [1 ]
机构
[1] Univ Sydney, Royal North Shore Hosp, Northern Clin Sch, Fac Med & Hlth,Kolling Inst Med Res, Level 7, Sydney, NSW, Australia
[2] NSW Hlth, Ctr Genet Educ, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney Hlth Eth, Sydney, NSW, Australia
关键词
Privacy; Genetic information; Disclosure without consent; Genetic counseling; Duty to warn; Genetic testing; Confidentiality; AT-RISK RELATIVES; FAMILY COMMUNICATION; INFORMATION; COUNSELORS; ATTITUDES; CANCER;
D O I
10.1186/s12910-020-0451-1
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Background When a genetic mutation is identified in a family member (proband), internationally, it is usually the proband's or another responsible family member's role to disclose the information to at-risk relatives. However, both active and passive non-disclosure in families occurs: choosing not to communicate the information or failing to communicate the information despite intention to do so, respectively. The ethical obligations to prevent harm to at-risk relatives and promote the duty of care by genetic health professionals (GHPs) is in conflict with Privacy laws and professional regulations that prohibits disclosure of information to a third party without the consent of the proband (duty of confidentiality). In New South Wales (NSW), Australia, amendments to Privacy legislation permits such disclosure to living genetic relatives with the process defined under guidelines although there is no legal duty to warn. This study assessed NSW GHP's awareness and experience of the legislation and guidelines. Methods An online survey collected demographics; theoretical knowledge; clinical scenarios to assess application knowledge; attitudes; confidence; experience with active non-disclosure. A link to correct answers was provided after completion. Knowledge scores above the median for non-parametric data or above the mean for parametric data were classified as 'good' or 'poor'. Chi square tests assessed associations between confidence and knowledge scores. Results While many of the 37 participants reported reading the guidelines, there was limited awareness of their scope and clinical application; that there is no legal duty to warn; and that the threat does not need to be imminent to warrant disclosure. No association between confidence and 'good' theoretical or applied clinical knowledge was identified. Uncertainty of their professional responsibility was identified and in the several case examples of active non-disclosure that were reported this uncertainty reflected the need for further understanding of the guidelines in regard to the processes required before disclosure was initiated. Conclusions There is a need for further education and training about the guidelines associated with the legislation that would be relevant to support disclosure. The findings may inform future strategies to support introduction of policy changes in other jurisdictions where similar regulatory regimes are introduced.
引用
收藏
页数:10
相关论文
共 22 条
  • [1] [Anonymous], MED L INT
  • [2] Bell D, 2001, Med Law Rev, V9, P130, DOI 10.1093/medlaw/9.2.130
  • [3] Centre for Genetics Education, 2016, NSW GUID FACT SHEET
  • [4] Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients
    Claes, E
    Evers-Kiebooms, G
    Boogaerts, A
    Decruyenaere, M
    Denayer, L
    Legius, E
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 116A (01) : 11 - 19
  • [5] Genetic professionals' reports of nondisclosure of genetic risk information within families
    Clarke, A
    Richards, M
    Kerzin-Storrar, L
    Halliday, J
    Young, MA
    Simpson, SA
    Featherstone, K
    Forrest, K
    Lucassen, A
    Morrison, PJ
    Quarrell, OWJ
    Stewart, H
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (05) : 556 - 562
  • [6] Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals
    Dheensa, Sandi
    Lucassen, Anneke
    Fenwick, Angela
    [J]. JOURNAL OF GENETIC COUNSELING, 2018, 27 (03) : 689 - 701
  • [7] Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals
    Dheensa, Sandi
    Fenwick, Angela
    Lucassen, Anneke
    [J]. BMJ OPEN, 2017, 7 (02):
  • [8] Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?
    Dove, Edward S.
    Chico, Vicky
    Fay, Michael
    Laurie, Graeme
    Lucassen, Anneke M.
    Postan, Emily
    [J]. JOURNAL OF MEDICAL ETHICS, 2019, 45 (08) : 504 - 507
  • [9] Duty to warn at-risk relatives for genetic disease: Genetic counselors' clinical experience
    Dugan, RB
    Wiesner, GL
    Juengst, ET
    O'Riordan, M
    Matthews, AL
    Robin, NH
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2003, 119C (01) : 27 - 34
  • [10] Guidelines for disclosing genetic information to family members:: From development to use
    Godard, B
    Hurlimann, T
    Letendre, M
    Égalité, N
    [J]. FAMILIAL CANCER, 2006, 5 (01) : 103 - 116